0 items USD 0.00Search
Your search for "Mantle%20cell%20lymphoma" gave back 45577 results.
Summary Publisher estimates that the Ibrutinib market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx...
Catalog:
HYR
April 2021
Price: USD 2,000.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global CAR-T Cell Immunotherapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Imbruvica market size was valued at US$ million in 2023. With growing demand in downstream market, the Imbruvica is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Asia Pacific minimal residual disease (MRD) testing market will grow by 15.5% annually with a total addressable market cap of $4,575.0 million over...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
Europe minimal residual disease (MRD) testing market was valued at $ 265.6 million in 2021 and will grow by 11.8% annually over 2021-2031, driven by...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
North America minimal residual disease (MRD) testing market is projected to grow by 11.1% annually in the forecast period and reach $ 1,056.1 million...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
Global minimal residual disease (MRD) testing market will reach $ 2,858.1 million by 2031, growing by 12.4% annually over 2021-2031, driven by the...
Catalog:
Grace Market Data
May 2022
Price: USD 3,480.00
Highlights The global Orelabrutinib Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The “CAR-T Cell Immunotherapy Industry Forecast” looks at past sales and reviews total world CAR-T Cell Immunotherapy sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global Ibrutinib BTK Inhibitors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The “Daratumumab Industry Forecast” looks at past sales and reviews total world Daratumumab sales in 2022, providing a comprehensive analysis by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
